Professional Documents
Culture Documents
Earnings Presentation
Earnings Presentation
2014 Highlights
Financials
Total revenue: R$2,246.5 MM (-5.0% )
Adj. expense: +2.9%, considerably below average inflation
Net income: R$977.1 MM (-9.7%)
Adj. net income: R$1,478.7 MM (-8.1%)
Adj. EPS: R$0.805 (-4.1%)
REFIS: net impact of R$63.1 MM (one-off charge in 3Q14)
1 Excludes depreciation, stock grant plan principal and social charges -, stock options plan, tax on dividends from the CME Group, transfer of fines collected, provisions
and discontinued operations. Excludes deferred taxes recognized in correlation with temporary differences from amortization of goodwill for tax purposes, stock
options plan cost, investment in associate (CME Group) accounted under the equity method of accounting, net of taxes related to dividends and taxes paid overseas to be
3
compensated. According to CVM Rule 527/12 that does not exclude equity method accounting.
Total Revenue
R$592.8 MM
: +2.9%
: +7.5%
: +6.5%
: -3.6%
: +5.8%
: +2.2%
: +6.4%
: +5.9%
2010 - 2014
: +8.9%
: +27.0%
Between 2010 and 2014,
adjusted expenses fell 14.3%
in real terms
WHAT EXPECT
FOR 2015
Corrected by IPCA.
1.8%
Third party
services
-12.8%
-19.5%
Marketing
-23.8%
-29.6%
-20.6%
-26.7%
Total
Personnel
Data
processing
10.2%
Real Change
48.5%
12.5%
Data
processing
-4.3%
Nominal
Change
19.7%
-14.3%
1,8%
Third party
services
Total
Personnel
2.8%
(in R$ millions)
-17.3%
-40.8%
Marketing
Real Change
-73.3%
-80.9%
Communicat.
Nominal
Change
Communicat.
-48.2%
-62.9%
(in R$ millions)
Includes personnel expenses and capitalization and excludes stock option and bonus expenses, Calculated based on the annual wage increase between 2010 and
2014 for personnel expenditure and the IPCA of services accumulated from Jan 2011 to Dec 2014 for the other lines of expenses
Financial Highlights
Consistently returning capital to shareholders, while preserving financial robustness
CASH AND FINANCIAL INVESTMENTS
(in R$ millions)
R$781.6 MM in 2014
Share buyback
2014: 90 MM shares (R$936.6 MM) repurchased, 4.8%
of the free-float
4Q14: 23 MM shares (R$228.5 MM)
New program: up to 60 MM shares in 2015
85 MM shares canceled (current share count 1.815 bi)
INVESTIMENTS (CAPEX)
FINANCIAL RESULT
10
Financial Highlights
Consistently returning capital to shareholders while preserving financial robustness
+
Share Buyback
More than 13% of freefloat repurchased in
almost 7 years (2H082014)
Cash Position
R$2,117 MM
Indebtedness
R$1,666 MM
Rating
Moodys
Baa1 (issuer global scale)
Baa2 (issuer BR scale)
Baa1 (global notes)
S&P
BBB (counterparty cred.)
A-2 (issuer)
Data of BM&FBOVESPA (not consolidated): excludes variation in financial transactions and collateral pledged by participants, proceeds raised in connection with the
acquisition of CME Group shares in 2010. Data from Dec 2014 and excludes third party resources (investors collateral, resources deposited in the BM&FBOVESPA Bank
and others).
11
Strategic Developments
Delivering on the strategic plan
Products/markets development
priorities
BM&FBOVESPA Clearinghouse
Listed products
Tesouro Direto
12
APPENDIX
13
14
Growth Products
Increasing revenue diversification
REVENUE GROWTH OF SELECTED PRODUCTS
Securities Lending
Tesouro Direto
Market maker for options on single stocks
Exchange traded funds (ETF)
Agribusiness credit bills (LCA)
Real estate investment funds (FII)
Non sponsored Brazilian Depositary Receipts (BDRs N1 NP)
CAGR
(2010-14):
+22.5%
(In R$ millions)
15
Financial Statements
Summary of Balance Sheet (Consolidated)
ASSETS
12/30/2014
12/31/2013
(in R$ millions)
2,785.2
4,319.5
500.5
1,196.6
1,962.3
2,853.4
Others
322.5
269.5
22,753.0
21,577.2
1,797.3
1,135.4
1,392.8
820.8
404.6
314.6
3,761.3
3,346.3
421.2
423.2
16,773.2
16,672.3
Others
Goodwill
16,064.3
16,064.3
Minority shareholdings
Total Assets
25,538.3
Current assets
Cash and cash equivalents
Financial investments
Others
Non-current assets
Long-term receivables
Financial investments
Others
Investments
Property and equipment
Intangible assets
12/30/2014 12/31/2013
1,891.8
2,710.8
1,321.9
2,073.0
569.9
637.9
Non-current liabilities
4,658.0
3,886.9
1,619.1
1,426.2
2,859.3
2,295.8
179.6
165.0
18,988.4
19,298.9
2,540.2
2,540.2
15,220.4
16,056.7
1,218.9
687.3
9.0
14.7
25,538.3
25,896.7
Current liabilities
Others
Shareholders equity
Capital stock
Capital reserve
16
Financial Statements
Net income and adjusted expenses reconciliations
ADJUSTED NET INCOME RECONCILIATION
4Q14
GAAP net income*
Stock options plan
Deferred tax liabilities
Equity in income of investees (net of taxes)
Recoverable taxes paid overseas
Adjusted net income
232.4
7.0
138.6
34.7
29.8
373.2
Change
Change
Change
3Q14
2014
2013
4Q14/4Q13
4Q14/3Q14
2014/2013
182.1
27.6%
238.4
-2.5%
977.1 1,081.5
-9.7%
6.8
3.4%
7.3
-4.6%
28.8
28.1
2.4%
138.9
-0.2%
138.6
0.0%
554.6
555.6
-0.2%
3.3
937.5%
43.7
-20.7%
162.7
120.4
35.2%
17.4
71.2%
16.7
78.9%
81.0
64.8
24.9%
341.9
9.2%
357.4
4.4% 1,478.7 1,609.8
-8.1%
4Q13
Total Expenses
Depreciation
Stock options plan
Tax on dividends from the CME Group
Provisions
Disc. BBM
Adjusted Expenses
250.4
(32.1)
(7.0)
(32.8)
(4.4)
0.9
174.9
4Q13
251.8
(31.2)
(6.8)
(36.2)
(10.8)
1.6
168.4
Change
4Q14/4Q13
-0.6%
2.9%
3.4%
-9.3%
-59.4%
3.8%
3.8%
3Q14
192.0
(29.5)
(7.3)
(5.8)
(4.3)
1.7
146.8
Change
4Q14/3Q14
30.4%
9.0%
-4.6%
469.5%
2.7%
19.1%
19.1%
2014
804.1
(119.1)
(28.8)
(49.4)
(19.5)
5.2
592.3
2013
790.8
(119.5)
(28.1)
(51.0)
(22.5)
6.1
575.8
Change
2014/2013
1.7%
-0.3%
2.4%
-3.1%
-13.1%
2.9%
2.9%
17
(in R$ millions)
Net revenues
4Q14
4Q13
Change
4Q14/4Q13
3Q14
Change
4Q14/3Q14
2014
2013
Change
2014/2013
533.4
474.4
12.4%
544.5
-2.0%
2,030.4
2,126.6
-4.5%
(250.4)
(251.8)
-0.6%
(192.0)
30.4%
(804.1)
(790.8)
1.7%
283.1
222.6
27.2%
352.5
-19.7%
1,226.4
1,335.8
-8.2%
53.1%
46.9%
614 bps
64.7%
-1.167 bps
60.4%
62.8%
-241 bps
67.5
39.5
70.7%
49.5
36.4%
212.2
171.4
23.8%
Financial result
54.1
51.5
5.0%
47.0
14.9%
208.2
180.7
15.2%
Net income*
232.4
182.1
27.6%
238.4
-2.5%
977.1
1,081.5
-9.7%
373.2
341.9
9.2%
357.4
4.4%
1,478.7
1,609.8
-8.1%
0.204
0.180
13.7%
0.195
4.5%
0.805
0.839
-4.1%
(174.9)
(168.4)
3.8%
(146.8)
19.1%
(592.3)
(575.8)
2.9%
Expenses
Operating income
Operating margin
Adjusted expenses
18
www.bmfbovespa.com.br/ir